Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Cytological diagnosis of malignant mesothelioma – improvement by additional determination of hyaluronic acid in pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 783s Year: 2006
Hyaluronic acid levels are increased in parapneumonic pleural effusions Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006
Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007
Utility of pleural fluid glucose measurement in TB pleural effusions. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010
Zoledronic acid limits experimental malignant pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 435s Year: 2007
Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Measurement of pleural fluid lactate dehydrogenase and adenosine deaminase for distinguishing malignant pleural effusions and other exudative pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 246s Year: 2004
C-reactive protein in differentiation between tuberculous and malignant pleural effusions Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011
Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid Source: Eur Respir J 2005; 26: Suppl. 49, 446s Year: 2005
Comparison of serum and bronchoalveolar lavage fluid sialic acid levels between malignant and benign lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002